The Southwest Oncology Group : Progress in Cancer ResearchCOLTMAN, Charles A.Seminars in oncology. 2008, Vol 35, Num 5, pp 545-552, issn 0093-7754, 8 p.Article

Estimated impact of the prostate cancer prevention trial on population mortalityUNGER, Joseph M; THOMPSON, Ian M; LEBLANC, Michael et al.Cancer. 2005, Vol 103, Num 7, pp 1375-1380, issn 0008-543X, 6 p.Article

Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupALBAIN, Kathy S; UNGER, Joseph M; CROWLEY, John J et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 14, pp 984-992, issn 0027-8874, 9 p.Article

The prostate cancer prevention trial : Current status and lessons learnedTHOMPSON, Ian M; KOURIL, Margaret; KLEIN, Eric A et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 230-234, issn 0090-4295Article

Prevention of prostate cancer with finasteride: US/European perspectiveTHOMPSON, Ian M; KLEIN, Eric A; LIPPMAN, Scott M et al.European urology. 2003, Vol 44, Num 6, pp 650-655, issn 0302-2838, 6 p.Article

Assessing prostate cancer risk : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 8, pp 529-534, issn 0027-8874, 6 p.Article

Effect of finasteride on the sensitivity of PSA for detecting prostate cancerTHOMPSON, Ian M; CHEN CHI; ANKERST, Donna Pauler et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 16, pp 1128-1133, issn 0027-8874, 6 p.Article

Erectile dysfunction and subsequent cardiovascular diseaseTHOMPSON, Ian M; TANGEN, Catherine M; GOODMAN, Phyllis J et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 23, pp 2996-3002, issn 0098-7484, 7 p.Article

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. CommentaryTHOMPSON, Ian M; TANGEN, Catherine M; GOODMAN, Phyllis J et al.The Journal of urology. 2007, Vol 177, Num 5, pp 1749-1752, issn 0022-5347, 4 p.Article

Prediction of prostate cancer for patients receiving finasteride : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of clinical oncology. 2007, Vol 25, Num 21, pp 3076-3081, issn 0732-183X, 6 p.Article

Finasteride Decreases the Risk of Prostatic Intraepithelial Neoplasia. CommentaryTHOMPSON, Ian M; LUCIA, M. Scott; REDMAN, Mary W et al.The Journal of urology. 2007, Vol 178, Num 1, pp 107-110, issn 0022-5347, 4 p.Article

Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliterTHOMPSON, Ian M; PAULER, Donna K; CROWLEY, John J et al.The New England journal of medicine. 2004, Vol 350, Num 22, pp 2239-2246, issn 0028-4793, 8 p.Article

Implementation of the Prostate Cancer Prevention Trial (PCPT)GOODMAN, Phyllis J; TANGEN, Catherine M; CROWLEY, John J et al.Controlled clinical trials. 2004, Vol 25, Num 2, pp 203-222, issn 0197-2456, 20 p.Article

The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate BiopsyTHOMPSON, Ian M; TANGEN, Catherine M; ANKERST, Donna P et al.The Journal of urology. 2008, Vol 180, Num 2, pp 544-547, issn 0022-5347, 4 p.Article

Longitudinal analysis of sexual function reported by men in the prostate cancer prevention trialMOINPOUR, Carol M; DARKE, Amy K; LIPPMAN, Scott M et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 13, pp 1025-1035, issn 0027-8874, 11 p.Article

Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trialsUNGER, Joseph M; COLTMAN, Charles A; ALBAIN, Kathy S et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 141-144, issn 0732-183X, 4 p.Article

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lowerTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 1, pp 66-70, issn 0098-7484, 5 p.Article

Southwest oncology group studies in bladder CancerCRAWFORD, E. David; WOOD, David P; PETRYLAK, Daniel P et al.Cancer. 2003, Vol 97, Num 8, pp 2099-2108, issn 0008-543X, 10 p., SUPConference Paper

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers : The Selenium and Vitamin E Cancer Prevention Trial (SELECT)LIPPMAN, Scott M; KLEIN, Eric A; KELLOGG PARSONS, J et al.JAMA, the journal of the American Medical Association. 2009, Vol 301, Num 1, pp 39-51, issn 0098-7484, 13 p.Article

Does the Level of Prostate Cancer Risk Affect Cancer Prevention with Finasteride?THOMPSON, Ian M; TANGEN, Catherine M; PARNES, Howard L et al.Urology (Ridgewood, NJ). 2008, Vol 71, Num 5, pp 854-857, issn 0090-4295, 4 p.Article

Finasteride and high-grade prostate cancer in the prostate cancer prevention trialLUCIA, M. Scott; EPSTEIN, Jonathan I; KATTAN, Michael W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 18, pp 1375-1383, issn 0027-8874, 9 p.Article

The prostate cancer prevention trial : Design, biases and interpretation of study resultsGOODMAN, Phyllis J; THOMPSON, Ian M; TANGEN, Catherine M et al.The Journal of urology. 2006, Vol 175, Num 6, pp 2234-2242, issn 0022-5347, 9 p.Article

The influence of finasteride on the development of prostate cancerTHOMPSON, Ian M; GOODMAN, Phyllis J; CARLIN, Susie M et al.The New England journal of medicine. 2003, Vol 349, Num 3, pp 215-224, issn 0028-4793, 10 p.Article